Skip to main content

Vestal Point Capital, LP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1974915 NEW YORK, NY

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,109,600
-$5,576,900 QoQ
Shares Held
4,320,000
-3.5% QoQ
Ownership
5.27%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#7
of 141 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $2,824,321,683 across 51 Biotechnology names. LXEO ranks #30 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,109,600 4,320,000
2026-03-31 $25,686,500 4,475,000
2025-12-31 $44,436,750 4,475,000
2025-09-30 $21,580,000 3,250,000
2025-06-30 $12,977,207 3,228,161
2025-03-31 $3,942,784 1,136,249
2024-12-31 $7,896,000 1,200,000
2024-09-30 $7,684,000 850,000
2024-06-30 $13,473,600 840,000
2024-03-31 $2,744,000 175,000